# Osimertinib versus afatinib in patients with T790M-positive, non-small-cell lung cancer and multiple central nervous system metastases after failure of initial EGFR-TKI treatment

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/osimertinib-versus-afatinib-in-patients-with-t790m-positive-non-small-cell-lung/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yang Yang,Qilong Liu,Lei Cao,Wei Sun,Xiaowei Gu,Bin Liu,Na Xiao,Fei Teng,Xiaoli Li,Mei-Ji Chen,Weiguang Yu,Huanyi Lin,Guixing Xu |
| Citations | 7 |
| DOI | 10.1186/s12890-021-01539-x |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://bmcpulmmed.biomedcentral.com/track/pdf/10.1186/s12890-021-01539-x |
| OpenAlex ID | https://openalex.org/W3119132968 |
| PMID | 34011336 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Xiaowei Gu](https://scholariq.org/researchers/xiaowei-gu/)

## Paper journal

- [BMC Pulmonary Medicine](https://scholariq.org/journals/bmc-pulmonary-medicine/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.